Biotech's Partner at Every Phase

2025 Pharmaceutical Technology Excellence Awards

Novotech is recognized across three key categories— Diversity, Research & Development, and Marketing—as part of the Pharmaceutical Technology Awards, one of the industry's most respected and widely recognized independent honors programs.

Insights That Accelerates Innovation

In clinical research, insight is momentum. By contributing our expertise and perspectives, we help advance development and improve outcomes for patients everywhere.

Whitepaper

The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology

Download
Webinar

Translating Early-Phase Radiopharma Innovation into Clinical Success: Perspectives from Investigator, Site, and CRO

Watch
Podcast

Navigating Regulatory Change & Market Shifts: CRO Perspectives

Listen
Article

South Korea and Australia Offer Solutions for Radiopharmaceutical Trial Bottlenecks

Read

Proven Industry Experience & Expertise

4450+
Trials
7260+
Trial Sites
4950+
Investigators
50+
Countries
60+
Drugs to Market

Novotech appoints Anand Tharmaratnam as new CEO

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue…

Obesity: Global Clinical Trial Landscape (2025)

Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)

Translating Early-Phase Radiopharma Innovation into Clinical Success: Perspectives from…

Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions

Phase III IPF Clinical Trial Delivered Across Asia-Pacific

How Is Early-phase Oncology Shaping The Next Generation Of Cancer Therapies?

The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology

Covid-19 Notice important updates

Find content relevant to:

Biotech moves fast. Your CRO should too.

OCT West Coast 2026

Medical and Regulatory Consulting

Patient Recruitment and Site Selection

Early Phase Trials in Australia

Clinical Operations and Project Management

Site Management Organization (SMO)

Biometrics CRO and Data Management

Real world data

Laboratory Services

FLEX

Oncology CRO services

Pharmacometric Services

Drug Development Consulting

GMO Solutions

Liver Disease CRO services

Infectious diseases and Vaccines CRO services

Orphan and rare disease CRO services

Clinical and Regulatory Strategy

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

Why Biotechs and Emerging Pharma Trust Novotech

2025 Pharmaceutical Technology Excellence Awards

Insights That Accelerates Innovation

The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology

Translating Early-Phase Radiopharma Innovation into Clinical Success: Perspectives from Investigator, Site, and CRO

Navigating Regulatory Change & Market Shifts: CRO Perspectives

South Korea and Australia Offer Solutions for Radiopharmaceutical Trial Bottlenecks

Proven Industry Experience & Expertise

4450+

Trials

7260+

Trial Sites

4950+

Investigators

50+

Countries

60+

Drugs to Market

Solutions Expertise